Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1799 2
1802 2
1807 1
1817 1
1818 2
1843 1
1868 1
1875 2
1879 1
1881 2
1909 2
1910 2
1911 2
1913 2
1915 1
1916 1
1917 2
1918 1
1920 2
1923 1
1924 1
1925 2
1926 3
1928 4
1929 3
1930 2
1931 2
1932 1
1933 2
1934 1
1936 1
1937 3
1939 3
1941 3
1942 3
1943 1
1944 2
1945 4
1946 22
1947 16
1948 16
1949 22
1950 25
1951 17
1952 26
1953 30
1954 33
1955 25
1956 35
1957 43
1958 32
1959 48
1960 47
1961 44
1962 37
1963 38
1964 62
1965 49
1966 69
1967 75
1968 71
1969 73
1970 74
1971 75
1972 95
1973 96
1974 103
1975 106
1976 111
1977 115
1978 130
1979 160
1980 139
1981 142
1982 148
1983 162
1984 139
1985 155
1986 171
1987 174
1988 171
1989 162
1990 184
1991 172
1992 161
1993 179
1994 170
1995 175
1996 152
1997 164
1998 151
1999 164
2000 170
2001 203
2002 206
2003 211
2004 240
2005 268
2006 268
2007 320
2008 294
2009 287
2010 366
2011 398
2012 400
2013 447
2014 419
2015 472
2016 471
2017 470
2018 483
2019 536
2020 649
2021 666
2022 311
Text availability
Article attribute
Article type
Publication date

Search Results

12,959 results
Results by year
Filters applied: . Clear all
Page 1
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.
O'Brien MP, Forleo-Neto E, Musser BJ, Isa F, Chan KC, Sarkar N, Bar KJ, Barnabas RV, Barouch DH, Cohen MS, Hurt CB, Burwen DR, Marovich MA, Hou P, Heirman I, Davis JD, Turner KC, Ramesh D, Mahmood A, Hooper AT, Hamilton JD, Kim Y, Purcell LA, Baum A, Kyratsous CA, Krainson J, Perez-Perez R, Mohseni R, Kowal B, DiCioccio AT, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos GD, Weinreich DM; Covid-19 Phase 3 Prevention Trial Team. O'Brien MP, et al. Among authors: davis jd. N Engl J Med. 2021 Sep 23;385(13):1184-1195. doi: 10.1056/NEJMoa2109682. Epub 2021 Aug 4. N Engl J Med. 2021. PMID: 34347950 Free PMC article. Clinical Trial.
REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19.
Weinreich DM, Sivapalasingam S, Norton T, Ali S, Gao H, Bhore R, Xiao J, Hooper AT, Hamilton JD, Musser BJ, Rofail D, Hussein M, Im J, Atmodjo DY, Perry C, Pan C, Mahmood A, Hosain R, Davis JD, Turner KC, Baum A, Kyratsous CA, Kim Y, Cook A, Kampman W, Roque-Guerrero L, Acloque G, Aazami H, Cannon K, Simón-Campos JA, Bocchini JA, Kowal B, DiCioccio AT, Soo Y, Geba GP, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos GD; Trial Investigators. Weinreich DM, et al. Among authors: davis jd. N Engl J Med. 2021 Dec 2;385(23):e81. doi: 10.1056/NEJMoa2108163. Epub 2021 Sep 29. N Engl J Med. 2021. PMID: 34587383 Free PMC article. Clinical Trial.
Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins.
Banskota S, Raguram A, Suh S, Du SW, Davis JR, Choi EH, Wang X, Nielsen SC, Newby GA, Randolph PB, Osborn MJ, Musunuru K, Palczewski K, Liu DR. Banskota S, et al. Among authors: davis jr. Cell. 2022 Jan 20;185(2):250-265.e16. doi: 10.1016/j.cell.2021.12.021. Epub 2022 Jan 11. Cell. 2022. PMID: 35021064 Free PMC article.
Subcutaneous REGEN-COV Antibody Combination for Covid-19 Prevention.
O'Brien MP, Forleo-Neto E, Musser BJ, Isa F, Chan KC, Sarkar N, Bar KJ, Barnabas RV, Barouch DH, Cohen MS, Hurt CB, Burwen DR, Marovich MA, Hou P, Heirman I, Davis JD, Turner KC, Ramesh D, Mahmood A, Hooper AT, Hamilton JD, Kim Y, Purcell LA, Baum A, Kyratsous CA, Krainson J, Perez-Perez R, Mohseni R, Kowal B, DiCioccio AT, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos GD, Weinreich DM. O'Brien MP, et al. Among authors: davis jd. medRxiv. 2021 Jun 17:2021.06.14.21258567. doi: 10.1101/2021.06.14.21258567. Preprint. medRxiv. 2021. PMID: 34159344 Free PMC article. Updated.
Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Caused by AmpC β-Lactamase-Producing Enterobacter spp, Citrobacter freundii, Morganella morganii, Providencia spp, or Serratia marcescens: A Pilot Multicenter Randomized Controlled Trial (MERINO-2).
Stewart AG, Paterson DL, Young B, Lye DC, Davis JS, Schneider K, Yilmaz M, Dinleyici R, Runnegar N, Henderson A, Archuleta S, Kalimuddin S, Forde BM, Chatfield MD, Bauer MJ, Lipman J, Harris-Brown T, Harris PNA; MERINO Trial Investigators and the Australasian Society for Infectious Disease Clinical Research Network (ASID-CRN). Stewart AG, et al. Among authors: davis js. Open Forum Infect Dis. 2021 Aug 2;8(8):ofab387. doi: 10.1093/ofid/ofab387. eCollection 2021 Aug. Open Forum Infect Dis. 2021. PMID: 34395716 Free PMC article.
The Immunology of Hormone Receptor Positive Breast Cancer.
Goldberg J, Pastorello RG, Vallius T, Davis J, Cui YX, Agudo J, Waks AG, Keenan T, McAllister SS, Tolaney SM, Mittendorf EA, Guerriero JL. Goldberg J, et al. Among authors: davis j. Front Immunol. 2021 May 11;12:674192. doi: 10.3389/fimmu.2021.674192. eCollection 2021. Front Immunol. 2021. PMID: 34135901 Free PMC article. Review.
PICC line management among patients with chronic kidney disease.
Oza-Gajera BP, Davis JA, Farrington C, Lerma EV, Moossavi S, Sheta MA, Dwyer A, Almehmi A. Oza-Gajera BP, et al. Among authors: davis ja. J Vasc Access. 2021 Jul 3:11297298211025897. doi: 10.1177/11297298211025897. Online ahead of print. J Vasc Access. 2021. PMID: 34218708
Cellular fluidics.
Dudukovic NA, Fong EJ, Gemeda HB, DeOtte JR, Cerón MR, Moran BD, Davis JT, Baker SE, Duoss EB. Dudukovic NA, et al. Among authors: davis jt. Nature. 2021 Jul;595(7865):58-65. doi: 10.1038/s41586-021-03603-2. Epub 2021 Jun 30. Nature. 2021. PMID: 34194019
12,959 results
You have reached the last available page of results. Please see the User Guide for more information.